Donepezil PRECAUTIONS, exporters, importers, manufacturers, suppliers,buyers and wholesalers,Raw Material ,overdose,search and directory ,medical information from Taj Pharmaceuticals Ltd. (Taj Group)

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Donepezil taj Pharmaceuticals Ltd.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Donepezil Manufacturers in India Suppliers Donepezil Exporters Distributors Donepezil api active pharmaceuticals ingredients Donepezil manufacturers Side Effects bulk drugs raw material Donepezil companies Side Effects Importers Donepezil Donepezil Exporters Donepezil exporters FDA Donepezil DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Donepezil manufacturing pharmaceutical drugs pharmaceutical intermediates Donepezil pharmaceutical chemicals pharmaceutical raw materials Donepezil active pharmaceutical ingredients Donepezil committee active pharmaceutical ingredients manufacturer Donepezil Active Pharmaceutical Ingredients manufacturer Donepezil exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Donepezil, Donepezil manufacturer India, Donepezil product, Donepezil products, Api preparation, Certificate of Analysis API manufacturer product, Donepezil anti ulcer product, Certificate of Origin COA Donepezil COS Donepezil, pharmaceutical generic, pharmaceutical drug, medical, Donepezil pharma healthcare, pharma patents, contract MSDS manufacturing Trader Donepezil pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Donepezil expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Donepezil DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Donepezil ingredients, api, HIV Donepezil, tablets, capsules, syrup & protein Donepezil powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Donepezil gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Donepezil WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Donepezil

HOME >> API >> API List1 >> Donepezil >> Precautions

PRECAUTIONS
Donepezil CAS Number 120014-06-4

No evidence of a carcinogenic potential was obtained in an 88-week carcinogenicity study of donepezil hydrochloride conducted in CD-1 mice at doses up to 180 mg/kg/day (approximately 90 times the maximum recommended human dose on a mg/m² basis), or in a 104-week carcinogenicity study in Sprague-Dawley rats at doses up to 30mg/kg/day (approximately 30 times the maximum recommended human dose on a mg/m² basis).

Donepezil was not mutagenic in the Ames reverse mutation assay in bacteria, or in a mouse lymphoma forward mutation assay in vitro. In the chromosome aberration test in cultures of Chinese hamster lung (CHL) cells, some clastogenic effects were observed. Donepezil was not clastogenic in the in vivo mouse micronucleus test and was not genotoxic in an in vivo unscheduled DNA synthesis assay in rats.

Donepezil had no effect on fertility in rats at doses up to 10 mg/kg/day (approximately 8 times the maximum recommended human dose on a mg/m² basis).

Pregnancy

Pregnancy Category C: Teratology studies conducted in pregnant rats at doses up to 16 mg/kg/day (approximately 13 times the maximum recommended human dose on a mg/m² basis) and in pregnant rabbits at doses up to 10 mg/kg/day (approximately 16 times the maximum recommended human dose on a mg/m² basis) did not disclose any evidence for a teratogenic potential of donepezil. However, in a study in which pregnant rats were given up to 10 mg/kg/day (approximately 8 times the maximum recommended human dose on a mg/m² basis) from day 17 of gestation through day 20 postpartum, there was a slight increase in still births and a slight decrease in pup survival through day 4 postpartum at this dose; the next lower dose tested was 3 mg/kg/day. There are no adequate or well-controlled studies in pregnant women. ARICEPT® should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Nursing Mothers

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS >>

INTERACTION

PHARMALOGY

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturing At Taj

Acamprosate Calcium	Clomipramine Hcl	Alendronate Sodium	Clonazepam	Amitriptyline	Clopidogrel Bisulfate	Anastrozole	Danazol	Atomoxetine Hcl	Desloratadine	Balsalazide
Desmopressin Monoacetate	Bicalutamide	Divalproex Sodium	Budesonide	Dobutamine Hcl	Bupropion Hcl	Donepezil	Calcitonin	Dothiepin Hcl	Capecitabine	Entacapone
Carbamazepine	Eptifibatide	Carboplatin	Escitalopram HBr	Carisoprodol	Eszopiclone	Carvedilol	Finasteride	Cefuroxime Axetil	Flurbiprofen	Cisplatin
Fluticasone Propionate	Citalopram Hbr	Fluvoxamine Maleate	Fosphenytoin Sodium

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.